Granules India inaugurates packaging facility in Virginia
The facility is over 79,000 square feet and is equipped with packaging lines
The facility is over 79,000 square feet and is equipped with packaging lines
Supply increase to help meet growing global demand
Virginia will be responsible for meeting client needs for both media and commercial analytics.
Investment will support AstraZeneca’s ambition to reach $80 billion revenue by 2030, with 50% generated in the US
Granules India receives 1 observation from USFDA for Chantilly facility
YESAFILI, a vascular endothelial growth factor (VEGF) inhibitor, is used to treat several different types of ophthalmology conditions
There are 38.4 million people with diabetes in the United States
Approval is based on positive data from the Phase 3 ECHELON-3 trial
Tyvek with Renewable Attribution is designed to help reduce the carbon footprint
Granules Pharmaceuticals gets 5 observations from USFDA on completion of GMP inspection
Subscribe To Our Newsletter & Stay Updated